Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Live-cell real-time imaging of mitochondria in HIV-1-infected cells.

Lee-Huang S, Huang PL, Huang PL.

AIDS Res Hum Retroviruses. 2014 Nov;30(11):1025-6. doi: 10.1089/aid.2014.0161. Epub 2014 Oct 2. No abstract available.

2.

Live-cell real-time imaging reveals role of mitochondria in cell-to-cell transmission of HIV-1.

Lee-Huang S, Lin Huang P, Lee Huang P.

Biochem Biophys Res Commun. 2011 Nov 18;415(2):384-9. doi: 10.1016/j.bbrc.2011.10.078. Epub 2011 Oct 20.

PMID:
22037455
3.

Computational study of bindings of HL9, a nonapeptide fragment of human lysozyme, to HIV-1 fusion protein gp41.

Hartono YD, Lee AN, Lee-Huang S, Zhang D.

Bioorg Med Chem Lett. 2011 Mar 15;21(6):1607-11. doi: 10.1016/j.bmcl.2011.01.121. Epub 2011 Feb 2.

PMID:
21334893
4.

A new activity of anti-HIV and anti-tumor protein GAP31: DNA adenosine glycosidase--structural and modeling insight into its functions.

Li HG, Huang PL, Zhang D, Sun Y, Chen HC, Zhang J, Huang PL, Kong XP, Lee-Huang S.

Biochem Biophys Res Commun. 2010 Jan 1;391(1):340-5. doi: 10.1016/j.bbrc.2009.11.060. Epub 2009 Nov 12.

PMID:
19913503
5.

Computational study of bindings of olive leaf extract (OLE) to HIV-1 fusion protein gp41.

Bao J, Zhang DW, Zhang JZ, Huang PL, Huang PL, Lee-Huang S.

FEBS Lett. 2007 Jun 12;581(14):2737-42. Epub 2007 May 21.

6.

Discovery of small-molecule HIV-1 fusion and integrase inhibitors oleuropein and hydroxytyrosol: Part I. fusion [corrected] inhibition.

Lee-Huang S, Huang PL, Zhang D, Lee JW, Bao J, Sun Y, Chang YT, Zhang J, Huang PL.

Biochem Biophys Res Commun. 2007 Mar 23;354(4):872-8. Epub 2007 Jan 24. Erratum in: Biochem Biophys Res Commun. 2007 May 18;356(4):1068.

7.

Discovery of small-molecule HIV-1 fusion and integrase inhibitors oleuropein and hydroxytyrosol: part II. integrase inhibition.

Lee-Huang S, Huang PL, Zhang D, Lee JW, Bao J, Sun Y, Chang YT, Zhang J, Huang PL.

Biochem Biophys Res Commun. 2007 Mar 23;354(4):879-84. Epub 2007 Jan 22.

8.

Structural and functional modeling of human lysozyme reveals a unique nonapeptide, HL9, with anti-HIV activity.

Lee-Huang S, Maiorov V, Huang PL, Ng A, Lee HC, Chang YT, Kallenbach N, Huang PL, Chen HC.

Biochemistry. 2005 Mar 29;44(12):4648-55.

PMID:
15779891
9.

Anti-HIV activity of olive leaf extract (OLE) and modulation of host cell gene expression by HIV-1 infection and OLE treatment.

Lee-Huang S, Zhang L, Huang PL, Chang YT, Huang PL.

Biochem Biophys Res Commun. 2003 Aug 8;307(4):1029-37.

PMID:
12878215
10.

Production of antiviral and antitumor proteins MAP30 and GAP31 in cucurbits using the plant virus vector ZYMV-AGII.

Arazi T, Lee Huang P, Huang PL, Zhang L, Moshe Shiboleth Y, Gal-On A, Lee-Huang S.

Biochem Biophys Res Commun. 2002 Mar 29;292(2):441-8.

PMID:
11906182
11.
12.

Inhibition of MDA-MB-231 human breast tumor xenografts and HER2 expression by anti-tumor agents GAP31 and MAP30.

Lee-Huang S, Huang PL, Sun Y, Chen HC, Kung HF, Huang PL, Murphy WJ.

Anticancer Res. 2000 Mar-Apr;20(2A):653-9.

PMID:
10810336
13.

Anti-HIV and anti-tumor protein MAP30, a 30 kDa single-strand type-I RIP, shares similar secondary structure and beta-sheet topology with the A chain of ricin, a type-II RIP.

Wang YX, Jacob J, Wingfield PT, Palmer I, Stahl SJ, Kaufman JD, Huang PL, Huang PL, Lee-Huang S, Torchia DA.

Protein Sci. 2000 Jan;9(1):138-44.

14.

Solution structure of anti-HIV-1 and anti-tumor protein MAP30: structural insights into its multiple functions.

Wang YX, Neamati N, Jacob J, Palmer I, Stahl SJ, Kaufman JD, Huang PL, Huang PL, Winslow HE, Pommier Y, Wingfield PT, Lee-Huang S, Bax A, Torchia DA.

Cell. 1999 Nov 12;99(4):433-42.

15.
16.

Proteolytic fragments of anti-HIV and anti-tumor proteins MAP30 and GAP31 are biologically active.

Huang PL, Sun Y, Chen HC, Kung HF, Lee-Huang S.

Biochem Biophys Res Commun. 1999 Sep 7;262(3):615-23.

PMID:
10471373
17.

Measurement of 3hJNC' connectivities across hydrogen bonds in a 30 kDa protein.

Wang YX, Jacob J, Cordier F, Wingfield P, Stahl SJ, Lee-Huang S, Torchia D, Grzesiek S, Bax A.

J Biomol NMR. 1999 Jun;14(2):181-4.

PMID:
10427744
18.

Lysozyme and RNases as anti-HIV components in beta-core preparations of human chorionic gonadotropin.

Lee-Huang S, Huang PL, Sun Y, Huang PL, Kung HF, Blithe DL, Chen HC.

Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2678-81.

19.

The activity of plant-derived antiretroviral proteins MAP30 and GAP31 against herpes simplex virus in vitro.

Bourinbaiar AS, Lee-Huang S.

Biochem Biophys Res Commun. 1996 Feb 27;219(3):923-9.

PMID:
8645280
20.

Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31.

Lee-Huang S, Huang PL, Huang PL, Bourinbaiar AS, Chen HC, Kung HF.

Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8818-22.

21.

Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon.

Lee-Huang S, Huang PL, Chen HC, Huang PL, Bourinbaiar A, Huang HI, Kung HF.

Gene. 1995 Aug 19;161(2):151-6.

PMID:
7665070
22.
23.
24.
25.
26.

Rational problems associated with the development of cellular approaches in controlling HIV spread.

Bourinbaiar AS, Lee-Huang S.

Adv Exp Med Biol. 1995;374:71-89. Review. No abstract available.

PMID:
7572402
27.

Anti-HIV effect of beta subunit of human chorionic gonadotropin (beta hCG) in vitro.

Bourinbaiar AS, Lee-Huang S.

Immunol Lett. 1995 Jan;44(1):13-8.

PMID:
7536708
28.

Human immunodeficiency virus type 1 (HIV-1) inhibition, DNA-binding, RNA-binding, and ribosome inactivation activities in the N-terminal segments of the plant anti-HIV protein GAP31.

Lee-Huang S, Kung HF, Huang PL, Bourinbaiar AS, Morell JL, Brown JH, Huang PL, Tsai WP, Chen AY, Huang HI, et al.

Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):12208-12.

29.

Crystallization and preliminary X-ray analysis of GAP 31. A protein which inhibits the life cycle of HIV-1.

Lee-Huang S, Kung HF, Chen HC, Huang PL, Rybak SM, Huang PL, Bourinbaiar AS, Musayev F, Liaw YC.

J Mol Biol. 1994 Jul 1;240(1):92-4.

PMID:
8021945
30.
31.

Inhibitory effect of the oral immune response modifier, bestatin, on cell-mediated and cell-free HIV infection in vitro.

Bourinbaiar AS, Lee-Huang S, Krasinski K, Borkowsky W.

Biomed Pharmacother. 1994;48(2):55-61.

PMID:
7919106
32.

Anti-HIV effect of immunomodulating agent, levamisole, in vitro.

Bourinbaiar AS, Lee-Huang S, Krasinski K, Borkowsky W.

Biomed Pharmacother. 1994;48(7):327-30.

PMID:
7858164
34.
35.

Anti-HIV plant proteins catalyze topological changes of DNA into inactive forms.

Huang PL, Chen HC, Kung HF, Huang PL, Huang P, Huang HI, Lee-Huang S.

Biofactors. 1992 Dec;4(1):37-41.

PMID:
1337969
36.

A new class of anti-HIV agents: GAP31, DAPs 30 and 32.

Lee-Huang S, Kung HF, Huang PL, Huang PL, Li BQ, Huang P, Huang HI, Chen HC.

FEBS Lett. 1991 Oct 7;291(1):139-44.

37.

TAP 29: an anti-human immunodeficiency virus protein from Trichosanthes kirilowii that is nontoxic to intact cells.

Lee-Huang S, Huang PL, Kung HF, Li BQ, Huang PL, Huang P, Huang HI, Chen HC.

Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6570-4.

38.

MAP 30: a new inhibitor of HIV-1 infection and replication.

Lee-Huang S, Huang PL, Nara PL, Chen HC, Kung HF, Huang P, Huang HI, Huang PL.

FEBS Lett. 1990 Oct 15;272(1-2):12-8.

39.

Anti-erythropoietin antibodies in hyperviscosity syndrome associated with giant lymph node hyperplasia (GLNH; Castleman's disease).

Steinberg JJ, Huang PL, Ljubich P, Lee-Huang S.

Br J Haematol. 1990 Apr;74(4):543-4. No abstract available.

PMID:
2346735
40.

Cloning and expression of human erythropoietin cDNA in Escherichia coli.

Lee-Huang S.

Proc Natl Acad Sci U S A. 1984 May;81(9):2708-12.

42.

Isolation and characterization of proteoglycans from human chondrosarcomas.

Pal S, Strider W, Margolis R, Gallo G, Lee-Huang S.

J Biol Chem. 1978 Feb 25;253(4):1279-89. No abstract available.

43.

Eucaryotic oligonucleotides affecting mRNA translation.

Lee-Huang S, Sierra JM, Naranjo R, Filipowicz W, Ochoa S.

Arch Biochem Biophys. 1977 Apr 30;180(2):276-87. No abstract available.

PMID:
879789
44.

Inhibition of polypeptide chain initiation in Escherichia coli by elongation factor G.

Lee-Huang S, Lee H, Ochoa S.

Proc Natl Acad Sci U S A. 1974 Aug;71(8):2928-31.

45.

Purification of two messenger-discriminating species of initiation factor 3 (IF3) from Escherichia coli.

Lee-Huang S, Ochoa S.

Methods Enzymol. 1974;30:45-53. No abstract available.

PMID:
4604999
46.

Preparation and properties of crystalline initiation factor 1 (IF1) from Escherichia coli.

Lee-Huang S, Ochoa S.

Methods Enzymol. 1974;30:31-9. No abstract available.

PMID:
4604930
47.

Factor requirements for initiation complex formation with natural and synthetic messengers in Escherichia coli systems.

Meier D, Lee-Huang S, Ochoa S.

J Biol Chem. 1973 Dec 25;248(24):8613-5. No abstract available.

48.

A specific inhibitor of polypeptide-chain initiation in Escherichia coli.

Lee-Huang S, Lee H, Ochoa S.

Proc Natl Acad Sci U S A. 1973 Oct;70(10):2874-8.

49.

Purification and properties of two messenger-discriminating species of E. coli initiation factor 3.

Lee-Huang S, Ochoa S.

Arch Biochem Biophys. 1973 May;156(1):84-96. No abstract available.

PMID:
4581139
50.

Specific inhibitors of MS2 and late T4 RNA translation in E. coli.

Lee-Huang S, Ochoa S.

Biochem Biophys Res Commun. 1972 Oct 17;49(2):371-6. No abstract available.

PMID:
4565492

Supplemental Content

Loading ...
Support Center